XML 31 R20.htm IDEA: XBRL DOCUMENT
v3.24.2.u1

Derivative Financial Instruments | 6 Months Ended
--- | ---
Jun. 30, 2024
Derivative Instruments and Hedging Activities Disclosure [Abstract] |
Derivative Financial Instruments | Derivative Financial Instruments Risk Management Objective of Using Derivatives The Company is exposed to certain risk arising from both its business operations and economic conditions. The Company principally manages its exposures to a wide variety of business and operational risks through management of its core business activities. The Company manages economic risks, including interest rate, liquidity, and credit risk primarily by managing the amount, sources, and duration of its assets and liabilities and the use of derivative financial instruments. Specifically, the Company enters into derivative financial instruments to manage exposures that arise from business activities that result in the receipt or payment of future known and uncertain cash amounts, the value of which are determined by interest rates. Cash Flow Hedges of Interest Rate Risk The Company’s objectives in using interest rate derivatives are to add stability to interest expense and to manage its exposure to interest rate movements. To accomplish this objective, the Company primarily uses interest rate swaps as part of its interest rate risk management strategy. Interest rate swaps designated as cash flow hedges involve the receipt of variable amounts from a counterparty in exchange for the Company making fixed-rate payments over the life of the agreements without exchange of the underlying notional amount. During 2024, such derivatives were used to hedge the variable cash flows associated with existing variable-rate debt. The Company had no fair value hedges nor derivatives not designated as hedges as of June 30, 2024. For derivatives designated and that qualify as cash flow hedges of interest rate risk, the gain or loss on the derivative is recorded in accumulated other comprehensive income ("OCI") and subsequently reclassified into interest expense in the same period(s) during which the hedged transaction affects earnings. Amounts reported in accumulated OCI related to derivatives will be reclassified to interest expense as interest payments are made on the Company’s variable-rate debt. During the next 12 months, the Company estimates that an additional $182 thousand will be reclassified as a reduction to interest expense. The table below presents the fair value of the Company’s derivative financial instruments as well as their classification on the Balance Sheet as of June 30, 2024:
|  | Derivative Assets |  | Derivative Liabilities
($ in thousands) |  | Notional Amount |  | Balance Sheet Location |  | Fair Value |  | Notional Amount |  | Balance Sheet Location |  | Fair Value
As of June 30, 2024 |  |  |  |  |  |  |  |  |  |  |  |
Derivatives designated as hedging instruments: |  |  |  |  |  |  |  |  |  |  |  |
Interest rate products |  | $ | — |  |  | Other assets |  | $ | — |  |  | $ | 50,000 |  |  | Other liabilities |  | $ | 254 |
Total derivatives designated as hedging instruments |  |  |  |  |  | $ | — |  |  |  |  |  |  | $ | 254 |
As of December 31, 2023, the Company had no derivative financial instruments. The table below presents the effect of cash flow hedge accounting on accumulated OCI for the three and six months ended June 30, 2024:
Derivatives in Subtopic 815-20 Hedging Relationships ($ in thousands) |  | Amount of Gain (Loss) Recognized in OCI on Derivative |  | Amount of Gain (Loss) Recognized in OCI Included Component |  | Amount of Gain (Loss) Recognized in OCI Excluded Component |  | Location of Gain (Loss) Recognized from Accumulated OCI into Income |  | Amount of Gain (Loss) Reclassified from Accumulated OCI into Income |  | Amount of Gain (Loss) Reclassified from Accumulated OCI into Income Included Component |  | Amount of Gain (Loss) Reclassified from Accumulated OCI into Income Excluded Component
Three Months Ended June 30, 2024 |  |  |  |  |  |  |  |  |  |  |  |  |  |
Derivatives in cash flow hedging relationships: |  |  |  |  |  |  |  |  |  |  |  |  |  |
Interest rate products |  | $ | (254) |  |  | $ | (254) |  |  | $ | — |  |  | Interest expense |  | $ | 81 |  |  | $ | 81 |  |  | $ | — |
Total |  | $ | (254) |  |  | $ | (254) |  |  | $ | — |  |  |  |  | $ | 81 |  |  | $ | 81 |  |  | $ | — |
Six Months Ended June 30, 2024 |  |  |  |  |  |  |  |  |  |  |  |  |  |
Derivatives in cash flow hedging relationships: |  |  |  |  |  |  |  |  |  |  |  |  |  |
Interest rate products |  | $ | (254) |  |  | $ | (254) |  |  | $ | — |  |  | Interest expense |  | $ | 81 |  |  | $ | 81 |  |  | $ | — |
Total |  | $ | (254) |  |  | $ | (254) |  |  | $ | — |  |  |  |  | $ | 81 |  |  | $ | 81 |  |  | $ | — |
The Company had no derivative instruments that affect accumulated OCI for the three and six months ended June 30, 2023. The table below presents the effect of the Company’s derivative financial instruments on the Statement of Income for the three and six months ended June 30, 2024:
|  | Three Months Ended June 30, 2024 | Six Months Ended June 30, 2024
($ in thousands) |  | Interest Income |  | Interest Expense |  | Interest Income |  | Interest Expense
Total amounts of income and expense line items presented in the statement of financial performance in which the effects of fair value or cash flow hedges are recorded |  | $ | — |  |  | $ | 81 |  |  | $ | — |  |  | $ | 81 |
The effects of cash flow hedging: |  |  |  |  |  |  |  |
Gain (loss) on cash flow hedging relationships in Subtopic 815-20 |  |  |  |  |  |  |  |
Interest contracts |  |  |  |  |  |  |  |
Amount of gain (loss) reclassified from accumulated OCI into income |  | $ | — |  |  | $ | 81 |  |  | $ | — |  |  | $ | 81 |
Amount of gain (loss) reclassified from accumulated OCI into income as a result that a forecasted transaction is no longer probable of occurring |  | — |  |  | — |  |  | — |  |  | — |
Amount of Gain (loss) reclassified from accumulated OCI into income - included component |  | — |  |  | 81 |  |  | — |  |  | 81 |
Amount of Gain (loss) reclassified from accumulated OCI into income - excluded component |  | — |  |  | — |  |  | — |  |  | — |
The Company had no derivative instruments that affect statement of income for the three and six months ended June 30, 2023. The table below presents a gross presentation, the effects of offsetting, and a net presentation of the Company’s derivatives as of June 30, 2024. The net amounts of derivative assets or liabilities can be reconciled to the tabular disclosure of fair value. The tabular disclosure of fair value provides the location that derivative assets and liabilities are presented on the Balance Sheet:
Offsetting of Derivative Assets |  |  |  |  |  |  |  |  |  |  |  |
|  | Gross Amounts of Recognized Assets |  | Gross Amounts Offset in the Balance Sheet |  | Net Amounts of Assets presented in the Balance Sheet |  | Gross Amounts Not Offset in the Balance Sheet
($ in thousands) |  |  |  |  | Financial Instruments |  | Cash Collateral Received |  | Net Amount
As of June 30, 2024 |  |  |  |  |  |  |  |  |  |  |  |
Derivatives |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | — |
Total |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | — |
Offsetting of Derivative Liabilities |  |  |  |  |  |  |  |  |  |  |  |
|  | Gross Amounts of Recognized Liabilities |  | Gross Amounts Offset in the Balance Sheet |  | Net Amounts of Liabilities presented in the Balance Sheet |  | Gross Amounts Not Offset in the Balance Sheet
($ in thousands) |  |  |  |  | Financial Instruments |  | Cash Collateral Posted |  | Net Amount
As of June 30, 2024 |  |  |  |  |  |  |  |  |  |  |  |
Derivatives |  | $ | 254 |  |  | $ | — |  |  | $ | 254 |  |  | $ | — |  |  | $ | — |  |  | $ | 254 |
Total |  | $ | 254 |  |  | $ | — |  |  | $ | 254 |  |  | $ | — |  |  | $ | — |  |  | $ | 254 |
As of December 31, 2023, the Company had no derivative financial instruments.

X
- References No definition available. + Details
Name: | us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 815 -SubTopic 40 -Name Accounting Standards Codification -Section 50 -Paragraph 5 -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480237/815-40-50-5 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 815 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 5C -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480434/815-10-50-5C Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 815 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/815/tableOfContent + Details
Name: | us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration